# Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin

> **NCT03801733** · PHASE1 · COMPLETED · sponsor: **Akebia Therapeutics** · enrollment: 134 (actual)

## Conditions studied

- Drug Interaction Potentiation

## Interventions

- **DRUG:** Vadadustat
- **DRUG:** Simvastatin
- **DRUG:** Rosuvastatin
- **DRUG:** Atorvastatin
- **DRUG:** Pravastatin
- **DRUG:** Sulfasalazine

## Key facts

- **NCT ID:** NCT03801733
- **Lead sponsor:** Akebia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-17
- **Primary completion:** 2018-11-24
- **Final completion:** 2018-11-24
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03801733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03801733, "Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03801733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*